Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 15 wrz 2022 · A commonly accepted paradigm (based on Virchow’s triad of thrombogenesis) posits the pathogenesis of LV thrombus as occurring as a result of the interplay of 3 factors: (1) stasis attributable to reduced ventricular function, (2) endocardial injury, and (3) inflammation/hypercoagulability (Figure 1).

    • View EPUB

      PK u!3Yoa«, mimetypeapplication/epub+zipPK u!3Y...

    • Linda S. Williams

      Similarly, wearable activity monitors and smartphone...

    • PDF/Epub

      PK u!3Yoa«, mimetypeapplication/epub+zipPK u!3Y...

    • Trial

      Background—The Randomized Evaluation of Long-term...

  2. 23 wrz 2022 · This AHA scientific statement was commissioned with the goals of addressing eight key clinical management questions related to LV thrombus, including the prevention and treatment after myocardial infarction (MI), prevention and treatment in dilated cardiomyopathy (DCM), management of mural (laminated) thrombus, imaging of LV thrombus, DOACs as ...

  3. Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study. Your access to the latest cardiovascular news, science, tools and resources.

  4. Introduction Left ventricular thrombus (LVT) is a frequent complication of left ventricular systolic dysfunction (1). Incidence following acute myocardial infarction is estimated at 13–20% and up to 15% in with non-ischaemic cardiomyopathy (2, 3). Once diagnosed, guidelines recommend anticoagulation with vitamin K antagonists (VKA) to reduce ...

  5. Left ventricular (LV) thrombus is a feared complication of LV dysfunction associated with high rates of systemic embolism, morbidity, and mortality. Traditionally, LV thrombus has been associated with acute myocardial infarction (MI).

  6. Here we propose an algorithmic approach to the diagnosis and management of left ventricular (LV) thrombus following acute myocardial infarction (AMI) that begins with transthoracic echocardiography (TTE) with contrast within 24 hours of index myocardial infarction (MI).

  7. Management of LV thrombus (LVT) is challenging and crucial to prevent the potential development of thromboembolic complications such as stroke. Anticoagulation with warfarin is recommended for the prevention of thromboembolic events, but novel oral anticoagulants (NOAC) have been used in clinical practice without supporting evidence.